Corneas can be repaired across a remarkably wide range of damage, from minor surface scratches that heal on their own within days to severe scarring or disease that requires replacing part or all of the tissue with donor material. The options available depend on which of the cornea’s layers are affected, how deep the damage runs, and whether the eye’s own regenerative machinery is still functioning. What surprises most people is how many steps exist between “wait and see” and a full transplant, and how much the field has changed in the past two decades.
How the Cornea Heals Itself
The cornea is only about half a millimeter thick, but it has distinct layers, and each one heals differently. The outermost layer, the epithelium, regenerates well. Stem cells concentrated at the limbus, the border between the cornea and the white of the eye, continuously produce new epithelial cells that migrate inward and upward to replace lost or damaged ones. These limbal stem cells maintain normal corneal health through a cycle of cell division, migration, and shedding from the surface.1PubMed Central. Limbal stem cells: Central concepts of corneal epithelial homeostasis A shallow abrasion that only removes epithelium typically closes within a few days without lasting damage.
Deeper layers are a different story. The stroma, which makes up most of the cornea’s thickness and is responsible for its transparency, does not regenerate cleanly. It tends to scar, leaving opaque patches that blur vision. The innermost layer, the endothelium, is a single sheet of cells that pumps fluid out of the cornea to keep it clear. In adults, endothelial cells do not divide to any meaningful degree. When enough of them die, the cornea swells and becomes cloudy, and no amount of waiting will fix it. Understanding which layer is involved is the first step in knowing which repair strategy makes sense.
When the Stem Cell Supply Fails
If a chemical burn, infection, or chronic inflammation destroys the limbal stem cells, the cornea loses its ability to renew its surface. Blood vessels and opaque conjunctival tissue creep across the cornea, a condition called limbal stem cell deficiency. At that point, even a healthy stroma underneath cannot maintain clear vision because the surface layer is no longer functioning properly.2PubMed Central. The diagnosis of limbal stem cell deficiency Recognizing this distinction matters because performing a standard corneal transplant on an eye with limbal stem cell deficiency is likely to fail. The new tissue will suffer the same surface breakdown unless the stem cell problem is addressed first.
Non-Surgical Repair Options
Many corneal problems, especially persistent surface wounds that refuse to close with standard lubricating drops, can be treated without surgery. The strategies range from specialized contact lenses to biologic drops made from a patient’s own blood.
Therapeutic Contact Lenses
Bandage soft lenses have been a staple for protecting a healing corneal surface, but scleral lenses represent a step up. These large-diameter rigid lenses vault over the entire cornea, creating a fluid reservoir against the eye’s surface. In one case involving a chronic epithelial defect that had resisted multiple other treatments, daily wear of a custom scleral lens over 18 months reduced the size and blood-vessel growth of the lesion and improved visual acuity from roughly 6/36 to 6/12.3PubMed. Therapeutic Scleral Lens Management of Corneal Epithelial Hypertrophy Secondary to a Corneal Persistent Epithelial Defect: A Case Report The constant bath of fluid shields the cornea from blinking friction and drying, giving it the protected environment it needs to recover.
Autologous Serum Eye Drops
When standard artificial tears and lubricants are not enough, eye drops made from a patient’s own blood serum offer a more biologically active alternative. The serum contains growth factors and vitamins that artificial drops lack, and it closely resembles natural tears in composition. In a study of 25 eyes with persistent epithelial defects that had not responded to conventional treatment, about two-thirds healed within four weeks of starting serum drops, at a concentration of 50%.4PubMed. Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects A larger comparative study found that undiluted serum drops achieved an overall healing rate near 87%, with a median time to full surface closure of about two weeks, compared with roughly 70% and four weeks in a control group.5Scientific Reports. Undiluted Serum Eye Drops for the Treatment of Persistent Corneal Epitheilal Defects Not every patient responds equally; defects caused by limbal stem cell deficiency tend to be harder to heal than those from other causes.
Amniotic Membrane
Cryopreserved amniotic membrane, the innermost layer of the placenta, can be placed directly on the cornea as a biological bandage. It contains anti-inflammatory compounds and promotes epithelial cell growth. In a case series of corneal abrasions, a self-retaining amniotic membrane achieved full surface healing in 70% of eyes within two days and in all eyes within a week, with no residual scarring.6Optometrical Clinical Practice. Cryopreserved Amniotic Membrane for Corneal Epithelial Abrasions: Case Series For deeper problems like corneal ulcers, a meta-analysis reported a pooled complete epithelial healing rate of 97% after amniotic membrane transplantation, though visual improvement was more variable, at around 53%.7PubMed. Effectiveness of Cryopreserved Amniotic Membrane Transplantation in Corneal Ulceration: A Meta-Analysis That gap between surface healing and visual recovery reflects the fact that while the membrane helps the wound close, it cannot undo stromal scarring that already exists.
Laser Treatment for Corneal Scars and Dystrophies
Phototherapeutic keratectomy, or PTK, uses an excimer laser to remove thin layers of diseased or scarred corneal tissue from the surface. It works best for opacities confined to the front portion of the stroma. The laser ablates tissue at precisely controlled depths, and the smoothing effect can reduce irregular astigmatism even when the scar is not completely eliminated.8PubMed Central. Pentacam-based phototherapeutic keratectomy outcome in superficial corneal opacities In patients with hereditary corneal dystrophies like granular or lattice dystrophy, PTK can clear enough of the superficial deposits to restore useful vision and delay or avoid the need for a corneal transplant.9PubMed. Excimer laser phototherapeutic keratectomy for granular and lattice corneal dystrophy: a comparative study Typical ablation depths run in the range of 50 to 200 micrometers, which is a meaningful fraction of the cornea’s total thickness, so the procedure requires careful imaging beforehand to ensure enough healthy tissue remains.10PubMed Central. Phototherapeutic Keratectomy Outcomes in Superficial Corneal Opacities
Collagen Cross-Linking for Keratoconus
Keratoconus is a progressive condition in which the cornea thins and bulges into a cone shape, distorting vision. For years the only options were rigid contact lenses to compensate for the irregular surface, or a corneal transplant when lenses were no longer adequate. Corneal collagen cross-linking changed that equation. The procedure uses riboflavin drops and ultraviolet-A light to create chemical bonds between collagen fibers in the stroma, stiffening the tissue. Studies at one year showed that cross-linking stopped keratoconus progression and produced measurable improvements in vision and corneal curvature.11PubMed Central. Collagen cross-linking with riboflavin and ultraviolet-A light in keratoconus: One-year results Five-year follow-up data confirmed that the treatment halted disease progression without safety concerns and could eliminate the need for a transplant.12PubMed. Corneal collagen cross-linking with riboflavin and ultraviolet a irradiation for keratoconus: long-term results
The picture beyond five years is less tidy. Longer-term data suggest the proportion of patients who remain stable declines over time, and some may need retreatment.13medRxiv. Long-term outcome of corneal collagen crosslinking with riboflavin and UV-A irradiation for keratoconus Cross-linking is best understood as a stabilizer, not a cure. It cannot reverse significant thinning or scarring that has already occurred, but it can buy time and, for many patients, prevent the condition from reaching the point where transplant surgery becomes necessary.
Corneal Transplant Surgery
When the damage goes too deep for surface treatments or laser work, replacing the affected corneal tissue with donor tissue remains the gold standard. The field has moved strongly toward replacing only the specific layer that is diseased, rather than swapping out the entire cornea.
Full-Thickness Transplant
Penetrating keratoplasty replaces all layers of the cornea with donor tissue. It has the longest track record and remains necessary for conditions that affect the full corneal thickness. First-time grafts have strong long-term survival, around 90% at five years and about 82% at ten years in large registry data.14PubMed. Long-term graft survival after penetrating keratoplasty Outcomes vary considerably by indication. Keratoconus grafts perform exceptionally well, with ten-year survival rates above 98% in one series, while grafts for conditions involving inflamed or vascularized corneas fare worse.15PubMed. A 10-year review of penetrating keratoplasty Immune rejection remains the leading cause of graft failure, and matching blood type between donor and recipient may reduce that risk.16PubMed Central. Advances in corneal graft rejection
Partial-Thickness Approaches
If only the front layers of the cornea are damaged, as in keratoconus or stromal scarring, a deep anterior lamellar keratoplasty (DALK) replaces the stroma while leaving the patient’s own endothelium intact. This avoids the risk of endothelial rejection entirely. Compared with full-thickness transplants for keratoconus, DALK carries a substantially lower risk of elevated eye pressure and postoperative cataract formation.17PubMed Central. Penetrating Keratoplasty versus Deep Anterior Lamellar Keratoplasty for Keratoconus: A Systematic Review and Meta-analysis
For diseases that primarily affect the endothelium, such as Fuchs’ dystrophy, surgeons now perform posterior lamellar procedures. Descemet membrane endothelial keratoplasty (DMEK) transplants only the thin endothelial layer and its basement membrane.18PubMed Central. Corneal Biomechanics Before and After Descemet Membrane Endothelial Keratoplasty in Patients with Fuchs Endothelial Corneal Dystrophy A closely related technique, Descemet stripping automated endothelial keratoplasty (DSAEK), includes a thin layer of stroma along with the endothelium, which makes the tissue slightly easier to handle.19PubMed. Descemet Stripping Automated Endothelial Keratoplasty versus Descemet Membrane Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy: A National Registry-Based Comparison Both procedures leave the patient’s own stroma and epithelium in place, which means smaller incisions, faster visual recovery, and fewer wound-related complications compared with a full-thickness transplant.
Artificial Corneas When Grafts Fail
Some eyes are too hostile for donor tissue to survive. Repeated graft failures, severe autoimmune conditions, and extensive chemical burns can make rejection nearly inevitable. In those cases, a keratoprosthesis, an artificial corneal device, offers an alternative. The Boston type 1 keratoprosthesis is the most widely used version. A systematic review comparing it with repeat donor transplant in patients with prior graft failures found that the artificial device produced more favorable visual outcomes and a greater likelihood of maintaining improved vision, without a higher rate of postoperative glaucoma.20PubMed. Boston Type 1 Keratoprosthesis versus Repeat Donor Keratoplasty for Corneal Graft Failure: A Systematic Review and Meta-analysis The most common indication for the device is failed penetrating keratoplasty, often after multiple previous grafts.21PubMed Central. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study A keratoprosthesis requires lifelong use of a daily antibiotic drop and regular monitoring, but for patients who have exhausted other options it can restore functional vision.
Regenerative Cell Therapies
The frontier of corneal repair is moving toward growing replacement cells in the laboratory rather than relying on whole-tissue grafts from donors.
Cultured Limbal Stem Cell Transplantation
For patients with limbal stem cell deficiency, particularly from chemical burns, surgeons can harvest a small biopsy of limbal tissue from the healthy eye, expand the cells in culture, and transplant the resulting sheet back onto the damaged cornea. This technique, known as cultured limbal epithelial transplantation, was one of the earliest clinical successes of regenerative medicine in any organ.22PubMed. Ex vivo cultured limbal epithelial transplantation. A clinical perspective It is best suited for unilateral injuries where one eye still has healthy stem cells to donate. If both eyes are damaged, donor tissue or alternative cell sources are needed, and the approach becomes more complex.23PubMed Central. The ocular surface chemical burns
Endothelial Cell Injection
Perhaps the most striking recent advance involves replacing endothelial cells without any transplant tissue at all. Researchers cultured human corneal endothelial cells in the lab, then injected them into the front chamber of the eye along with a ROCK inhibitor, a drug that helps the cells attach and survive on the inner corneal surface.24PubMed Central. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction In a first-in-human clinical study of 11 eyes with bullous keratopathy, all treated eyes achieved endothelial cell counts above 500 cells per square millimeter at 24 weeks, and nine out of eleven gained at least two lines of visual acuity.25PubMed. Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy If this approach scales up, it could dramatically reduce the dependence on donor corneas for endothelial diseases like Fuchs’ dystrophy and bullous keratopathy, which together account for the majority of corneal transplants performed worldwide.
Gene Editing and Hereditary Corneal Disease
Some corneal conditions are genetic, meaning the cells keep producing abnormal proteins even after a transplant. Granular corneal dystrophy, for example, causes protein deposits to accumulate in the stroma, and these deposits can recur in grafted tissue because the patient’s own keratocytes eventually repopulate the graft. Gene therapy aims to fix the underlying mutation instead. Researchers have used CRISPR-Cas9 to correct the specific mutation responsible for granular corneal dystrophy type 2 in patient-derived corneal cells grown in the lab. The correction efficiency reached about 21% in cells with one copy of the mutation and 41% in cells with two copies, with no detectable off-target effects.26PubMed Central. Repair of the TGFBI gene in human corneal keratocytes derived from a granular corneal dystrophy patient via CRISPR/Cas9-induced homology-directed repair This remains at the laboratory stage, not yet tested in living human eyes, but it points toward a future where hereditary corneal diseases could be treated at their root.27PubMed Central. Corneal Regeneration Using Gene Therapy Approaches
Bioengineered and Animal-Derived Corneas
The global shortage of donor corneas is severe, with developing nations particularly affected.28PubMed Central. Corneal blindness in the developing world: The role of prevention strategies Two parallel efforts aim to reduce dependence on human donors. The first is 3D bioprinting, which uses bio-inks loaded with corneal cells and collagen to print layered structures that mimic the native cornea. The technology is advancing rapidly and has produced constructs with promising transparency and mechanical strength, but no bioprinted cornea has yet been used in routine clinical practice.29PubMed Central. Advances in 3D bioprinting technology for functional corneal reconstruction and regeneration
The second approach uses decellularized porcine corneal tissue. Pig corneas are structurally similar to human corneas, and removing all pig cells while preserving the collagen scaffold produces a graft that human cells can gradually repopulate. In animal studies, cross-linked decellularized porcine corneal grafts restored transparency and showed no rejection over a year of follow-up.30Scientific Reports. Cross-linked decellularized porcine corneal graft for treating fungal keratitis 31PubMed Central. Application of benzonase in preparation of decellularized lamellar porcine corneal stroma for lamellar keratoplasty Early human trials of pig-derived implants have generated considerable excitement, and if they prove safe and effective at scale, they could transform access to corneal surgery in regions where eye banking infrastructure is limited.
How Doctors Track Repair After Treatment
One underappreciated piece of corneal repair is the imaging that guides and monitors it. Ultrahigh-resolution anterior segment optical coherence tomography (OCT) can measure individual corneal layers with micrometer precision. After cross-linking for keratoconus, for instance, this imaging shows the epithelium thinning during the early healing phase and reveals the demarcation line, a visible boundary in the stroma that confirms how deeply the treatment penetrated.32PubMed Central. Ultrahigh‐resolution anterior segment optical coherence tomography for analysis of corneal microarchitecture during wound healing These imaging advances matter because they allow doctors to catch incomplete healing, early rejection, or graft thinning long before the patient notices a change in vision. For patients, it means fewer surprises and earlier interventions when something goes wrong.